Abeona Therapeutics (ABEO) Tops Q2 EPS by 209c

Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of $1.71, $2.09 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Hunterbrook bullish on Modine Manufacturing (MOD)
• Citadel has shed over 80% of aggregate risk from Situational Awareness portfolio - CNBC